PDX-1 is a therapeutic target for pancreatic cancer, insulinoma and islet neoplasia using a novel RNA interference platform

Shi He Liu, Donald D. Rao, John Nemunaitis, Neil Senzer, Guisheng Zhou, David Dawson, Marie Claude Gingras, Zhaohui Wang, Richard Gibbs, Michael Norman, Nancy S. Templeton, Francesco J. DeMayo, Bert O'Malley, Robbi Sanchez, William E. Fisher, F. Charles Brunicardi